P45.06 Overall Survival From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1+ Advanced Non-Small-Cell Lung Cancer
Keyword(s):
Phase 2
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 17
(5)
◽
pp. e103-e112
◽
Keyword(s):
2010 ◽
Vol 5
(10)
◽
pp. 1609-1615
◽
Keyword(s):
2018 ◽
Vol 13
(10)
◽
pp. 1539-1548
◽
Keyword(s):